CONTINENTAL STRATEGY, LLC

Lobbying for VIVEX BIOLOGICS · regenerative medicine company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Florida · $120,000.00 income · posted Jul 19, 2026

Lobbying activity 2

Science/Technology

regenerative and innovative medical solutions

Health Issues

regenerative and innovative medical solutions

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.